These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
162 related items for PubMed ID: 1337997
1. Relationship between melanogenesis, glutathione levels and melphalan toxicity in human melanoma cells. Benathan M, Alvero-Jackson H, Mooy AM, Scaletta C, Frenk E. Melanoma Res; 1992 Dec; 2(5-6):305-14. PubMed ID: 1337997 [Abstract] [Full Text] [Related]
2. Melanin content and downregulation of glutathione S-transferase contribute to the action of L-buthionine-S-sulfoximine on human melanoma. Fruehauf JP, Zonis S, al-Bassam M, Kyshtoobayeva A, Dasgupta C, Milovanovic T, Parker RJ, Buzaid AC. Chem Biol Interact; 1998 Apr 24; 111-112():277-305. PubMed ID: 9679561 [Abstract] [Full Text] [Related]
3. Characteristics of the glutathione/glutathione-S-transferase detoxification system in melphalan resistant human prostate cancer cells. Ripple M, Mulcahy RT, Wilding G. J Urol; 1993 Jul 24; 150(1):209-14. PubMed ID: 8510259 [Abstract] [Full Text] [Related]
4. Nitrogen mustard-DNA interaction in melphalan-resistant mammary carcinoma cells with elevated intracellular glutathione and glutathione-S-transferase activity. Alaoui-Jamali MA, Panasci L, Centurioni GM, Schecter R, Lehnert S, Batist G. Cancer Chemother Pharmacol; 1992 Jul 24; 30(5):341-7. PubMed ID: 1505071 [Abstract] [Full Text] [Related]
5. Modulation of 5-S-cysteinyldopa formation by tyrosinase activity and intracellular thiols in human melanoma cells. Benathan M. Melanoma Res; 1996 Jun 24; 6(3):183-9. PubMed ID: 8819121 [Abstract] [Full Text] [Related]
6. Sensitivity of human melanoma cells to L-dopa and DL-buthionine (S,R)-sulfoximine. Kable EP, Favier D, Parsons PG. Cancer Res; 1989 May 01; 49(9):2327-31. PubMed ID: 2706620 [Abstract] [Full Text] [Related]
7. Mitomycin C sensitivity in human bladder cancer cells: possible role of glutathione and glutathione transferase in resistance. Xu BH, Gupta V, Singh SV. Arch Biochem Biophys; 1994 Jan 01; 308(1):164-70. PubMed ID: 8311448 [Abstract] [Full Text] [Related]
8. Selective and synergistic activity of L-S,R-buthionine sulfoximine on malignant melanoma is accompanied by decreased expression of glutathione-S-transferase. Fruehauf JP, Zonis S, al-Bassam M, Kyshtoobayeva A, Dasgupta C, Milovanovic T, Parker RJ, Buzaid AC. Pigment Cell Res; 1997 Aug 01; 10(4):236-49. PubMed ID: 9263331 [Abstract] [Full Text] [Related]
9. Role of cellular glutathione and glutathione S-transferase in the expression of alkylating agent cytotoxicity in human breast cancer cells. Chen G, Waxman DJ. Biochem Pharmacol; 1994 Mar 15; 47(6):1079-87. PubMed ID: 8147907 [Abstract] [Full Text] [Related]
10. Glutathione efflux associated with a low gamma-glutamyl transpeptidase activity in human melanoma cells. Benathan M. Br J Dermatol; 1997 Nov 15; 137(5):721-7. PubMed ID: 9415231 [Abstract] [Full Text] [Related]
11. Enhanced melphalan cytotoxicity in human ovarian cancer in vitro and in tumor-bearing nude mice by buthionine sulfoximine depletion of glutathione. Ozols RF, Louie KG, Plowman J, Behrens BC, Fine RL, Dykes D, Hamilton TC. Biochem Pharmacol; 1987 Jan 01; 36(1):147-53. PubMed ID: 3801051 [Abstract] [Full Text] [Related]
12. Co-regulation of melanin precursors and tyrosinase in human pigment cells: roles of cysteine and glutathione. Benathan M, Virador V, Furumura M, Kobayashi N, Panizzon RG, Hearing VJ. Cell Mol Biol (Noisy-le-grand); 1999 Nov 01; 45(7):981-90. PubMed ID: 10644002 [Abstract] [Full Text] [Related]
13. In-transit melanoma: the role of alkylating-agent resistance in regional therapy. Grubbs EG, Abdel-Wahab O, Cheng TY, Abdel-Wahab Z, Peterson B, Pruitt SK, Colvin OM, Friedman HS, Tyler DS. J Am Coll Surg; 2004 Sep 01; 199(3):419-27. PubMed ID: 15325612 [Abstract] [Full Text] [Related]
14. Effect of D,L-buthionine-S,R-sulfoximine on cytotoxicity and DNA cross-linking induced by bifunctional DNA-reactive cytostatic drugs in human melanoma cells. Hansson J, Edgren M, Ehrsson H, Ringborg U, Nilsson B. Cancer Res; 1988 Jan 01; 48(1):19-26. PubMed ID: 3334994 [Abstract] [Full Text] [Related]
15. The relationships between glutathione, glutathione-S-transferase and cytotoxicity of platinum drugs and melphalan in eight human ovarian carcinoma cell lines. Mistry P, Kelland LR, Abel G, Sidhar S, Harrap KR. Br J Cancer; 1991 Aug 01; 64(2):215-20. PubMed ID: 1892748 [Abstract] [Full Text] [Related]
16. Enhancement of melphalan activity by buthionine sulfoximine and electroporation in melanoma cells. Ongaro A, Pellati A, De Mattei M, De Terlizzi F, Rossi CR, Campana LG. Anticancer Drugs; 2015 Mar 01; 26(3):284-92. PubMed ID: 25514113 [Abstract] [Full Text] [Related]
17. Differential sensitivities of murine melanocytes and melanoma cells to buthionine sulfoximine and anticancer drugs. Thrall BD, Raha GA, Springer DL, Meadows GG. Pigment Cell Res; 1991 Dec 01; 4(5-6):234-9. PubMed ID: 1823927 [Abstract] [Full Text] [Related]
18. Glutathione depletion increases the cytotoxicity of melphalan to PC-3, an androgen-insensitive prostate cancer cell line. Canada A, Herman L, Kidd K, Robertson C, Trump D. Cancer Chemother Pharmacol; 1993 Dec 01; 32(1):73-7. PubMed ID: 8462127 [Abstract] [Full Text] [Related]
19. UVA-induced melanogenesis and modulation of glutathione redox system in different melanoma cell lines: the protective effect of gallic acid. Panich U, Onkoksoong T, Limsaengurai S, Akarasereenont P, Wongkajornsilp A. J Photochem Photobiol B; 2012 Mar 01; 108():16-22. PubMed ID: 22244344 [Abstract] [Full Text] [Related]
20. Markedly decreased expression of glutathione S-transferase pi gene in human cancer cell lines resistant to buthionine sulfoximine, an inhibitor of cellular glutathione synthesis. Yokomizo A, Kohno K, Wada M, Ono M, Morrow CS, Cowan KH, Kuwano M. J Biol Chem; 1995 Aug 18; 270(33):19451-7. PubMed ID: 7642628 [Abstract] [Full Text] [Related] Page: [Next] [New Search]